Asterias Biotherapeutics Inc. Common Series A (AST) Slipped -5.56% or -0.12 To Price $2.12 On Tuesday


Asterias Biotherapeutics Inc. Common Series A (AST) slipped -5.56% or -0.12 to $2.12. It is around 68792 shares traded, which is 46.35% compare to the average total volume 148428. The market cap of AST is $115.07 million. The 52 week price range is from $1.95 to $5.0. Price of AST have changed 4.65% during last week. It have changed -2.17% over last month, -37.50% over last 3 months, -39.19% over last 6 months and -50.55% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AST is 2.37. It is 11.79% above current price. The 200-day Moving Averages for AST is 3.08. It is 45.28% above current price. The 52-week High is 5.0. It is 135.85% from the current price. The 52-week Low is 1.95. It is -8.02% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AST is 19.06 on 2017-12-15. Short % to float is 5.05%. There are some statistics of AST. It is has market cap $115.07 million. The share outstanding is 54.15 million. The average volume is 148428. The percent of top 15 Institution holding is 14.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AST is -83.72%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AST is -54.86%.


Tags:

Share this post